Starling Medical Company Overview
Starling Medical uses artificial intelligence and mechanical innovation to develop a tech-enabled urinary catheter for patients with neurogenic bladder dysfunction. It helps replace urinary catheter use for severe neurogenic bladder patients. The company's diagnostic devices and software infrastructure seamlessly integrate into anyone's bathroom routine for enhanced freedom and independence. Starling won the 2021 Texas A&M New Ventures Competition. Starling Medical has raised $4.24 million over five rounds from investors, including Rebel Fund, Coho Deeptech, and Centauri Fun.
Starling Medical Stock Price
The stock price of Starling Medical can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
Buy Starling Medical Stock
If you would like to buy shares in Starling Medical, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Starling Medical stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Starling Medical as well.
Starling Medical Management
| Name | Position |
|---|---|
| Hannah McKenney | CEO |
